ICELEA
Fixed-dose combination of antiretroviral agents for the treatment of adult and adolescent patients ≥12 years (≥35kg) with HIV-1. It is used as part of a combination treatment regimen. Due to its composition, it causes less bone and renal involvement.
Therapeutic Area
HIV + Infectology
Active Ingredient
Emtricitabine
Line
Anti-infectives + HIV - Antivirals
Dosage forms
30 coated tablets containing TAF 25mg/embricitabine 200mg
